New Zealand markets open in 2 hours

Catheter Precision, Inc. (VTAK)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
0.5900-0.0087 (-1.45%)
At close: 03:41PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.53M
Enterprise value 3.30M
Trailing P/E 0.05
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)9.10
Price/book (mrq)0.24
Enterprise value/revenue 7.51
Enterprise value/EBITDA 0.27

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-46.90%
S&P500 52-week change 326.16%
52-week high 31.3200
52-week low 30.3400
50-day moving average 30.5230
200-day moving average 30.4848

Share statistics

Avg vol (3-month) 338.52k
Avg vol (10-day) 347.06k
Shares outstanding 57.57M
Implied shares outstanding 67.68M
Float 85.76M
% held by insiders 117.31%
% held by institutions 15.43%
Shares short (30 Apr 2024) 425.56k
Short ratio (30 Apr 2024) 40.64
Short % of float (30 Apr 2024) 40.39%
Short % of shares outstanding (30 Apr 2024) 40.34%
Shares short (prior month 28 Mar 2024) 417.55k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 317 Nov 2020
Ex-dividend date 4N/A
Last split factor 21:50
Last split date 303 Oct 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-3,190.24%

Management effectiveness

Return on assets (ttm)-15.36%
Return on equity (ttm)-25.18%

Income statement

Revenue (ttm)439k
Revenue per share (ttm)0.07
Quarterly revenue growth (yoy)-3.50%
Gross profit (ttm)N/A
EBITDA -8.25M
Net income avi to common (ttm)-6.85M
Diluted EPS (ttm)11.3000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.49M
Total cash per share (mrq)0.2
Total debt (mrq)254k
Total debt/equity (mrq)1.37%
Current ratio (mrq)0.83
Book value per share (mrq)2.45

Cash flow statement

Operating cash flow (ttm)-10.51M
Levered free cash flow (ttm)-5.71M